Acquired thrombophilias and pregnancy.

[1]  C. Nzerue,et al.  "Black swan in the kidney": renal involvement in the antiphospholipid antibody syndrome. , 2002, Kidney international.

[2]  R. Roubey.  Treatment of the antiphospholipid syndrome. , 2002, Current opinion in rheumatology.

[3]  N. Sebire,et al.  Placental massive perivillous fibrin deposition associated with antiphospholipid antibody syndrome , 2002, BJOG : an international journal of obstetrics and gynaecology.

[4]  S. Bewley,et al.  Antiphospholipid antibodies do not a syndrome make , 2002, Lupus.

[5]  K. Nicolaides,et al.  Multicenter screening for pre‐eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation , 2001, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[6]  G. M. Iverson,et al.  Synthesis of LJP 993, a multivalent conjugate of the N-terminal domain of beta2GPI and suppression of an anti-beta2GPI immune response. , 2001, Bioconjugate chemistry.

[7]  A. Borel‐Derlon,et al.  Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies , 2001, BJOG : an international journal of obstetrics and gynaecology.

[8]  K. Nicolaides,et al.  Individualized Risk Assessment for Adverse Pregnancy Outcome by Uterine Artery Doppler at 23 Weeks , 2001, Obstetrics and gynecology.

[9]  M. Khamashta,et al.  Management of pregnancy in antiphospholipid syndrome. , 2001, Rheumatic diseases clinics of North America.

[10]  M. Khamashta,et al.  Aspirin to treat obstetric manifestations of the antiphospholipid syndrome. , 2001, American journal of obstetrics and gynecology.

[11]  Y. Shoenfeld,et al.  Induction and treatment of the antiphospholipid syndrome – lessons from animal models , 2001, European journal of clinical investigation.

[12]  A. Gharavi,et al.  Testing for antiphospholipid antibodies: problems and solutions. , 2001, Clinical obstetrics and gynecology.

[13]  M. Esplin.  Management of antiphospholipid syndrome during pregnancy. , 2001, Clinical obstetrics and gynecology.

[14]  L. Poston,et al.  Placentation, antiphospholipid syndrome and pregnancy outcome , 2001, Lupus.

[15]  J. Morrow,et al.  Antioxidant susceptibility of pathogenic pathways in subjects with antiphospholipid antibodies: a pilot study , 2000, Lupus.

[16]  N. Pattison,et al.  Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. , 2000, American journal of obstetrics and gynecology.

[17]  M. Petri.  Epidemiology of the antiphospholipid antibody syndrome. , 2000, Journal of autoimmunity.

[18]  H. Cohen,et al.  Guidelines On The Investigation and Management Of The Antiphospholipid Syndrome , 2000, British journal of haematology.

[19]  K. Khan,et al.  How useful is uterine artery Doppler flow velocimetry in the prediction of pre‐eclampsia, intrauterine growth retardation and perinatal death? An overview , 2000, BJOG : an international journal of obstetrics and gynaecology.

[20]  P. Casali,et al.  Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. , 2000, Arthritis and rheumatism.

[21]  Y. El‐Sayed,et al.  A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. , 2000, American journal of obstetrics and gynecology.

[22]  L. Poston,et al.  Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial , 1999, The Lancet.

[23]  B. Brenner,et al.  Safety of Low-Molecular-Weight Heparin in Pregnancy: A Systematic Review , 1999, Thrombosis and Haemostasis.

[24]  H. Cohen,et al.  Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin , 1999, British journal of obstetrics and gynaecology.

[25]  M. Mitchell,et al.  Action of anticardiolipin and antibodies to β2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death , 1998, The Lancet.

[26]  N. Raine-Fenning,et al.  Intravenous immunoglobulin therapy in compromised pregnancies associated with antiphospholipid antibodies and systemic lupus erythematosus. , 1998, European journal of obstetrics, gynecology, and reproductive biology.

[27]  M. Swiet,et al.  3 Acquired thrombophilia , 1997 .

[28]  S. Todesco,et al.  A prospective study of fifty-three consecutive calcium heparin treated pregnancies in patients with antiphospholipid antibody-related fetal loss. , 1997, Clinical and experimental rheumatology.

[29]  C. Feighery,et al.  Antibodies to β2‐glycoprotein I—a specific marker for the antiphospholipid syndrome , 1997, Clinical and experimental immunology.

[30]  C. Nelson-Piercy.  Review : Heparin-induced osteoporosis in pregnancy , 1997 .

[31]  K. Granger,et al.  Review : Obstetric outcome in antiphospholipid syndrome , 1997 .

[32]  C. Nelson-Piercy,et al.  Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk. , 1997, American journal of obstetrics and gynecology.

[33]  E. Reece,et al.  Do low-risk pregnant women with antiphospholipid antibodies need to be treated? Organizing Group of the Antiphospholipid Antibody Treatment Trial. , 1997, American journal of obstetrics and gynecology.

[34]  D. Ringrose.  Anaesthesia and the antiphospholipid syndrome: a review of 20 obstetric patients. , 1997, International journal of obstetric anesthesia.

[35]  H. Cohen,et al.  Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) , 1997, BMJ.

[36]  G. Hughes,et al.  Thromboprophylaxis with Low Molecular Weight Heparin (Fragmin) in High Risk Pregnancies , 1997, Thrombosis and Haemostasis.

[37]  Ras Roubey,et al.  Antigenic Specificities of Antiphospholipid Autoantibodies: Implications for Clinical Laboratory Testing and Diagnosis of the Antiphospholipid Syndrome , 1996, Lupus.

[38]  W. Kutteh.  Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. , 1996, American journal of obstetrics and gynecology.

[39]  R. Silver,et al.  Antiphospholipid Antibodies and Fetal Death , 1996, Obstetrics and gynecology.

[40]  G. Hughes,et al.  A study of sixty pregnancies in patients with the antiphospholipid syndrome. , 1996, Clinical and experimental rheumatology.

[41]  J. Brandt,et al.  Laboratory Identification of Lupus Anticoagulants: Results of the Second International Workshop for Identification of Lupus Anticoagulants , 1995, Thrombosis and Haemostasis.

[42]  S. Ostlere,et al.  Pregnancy-associated osteoporosis. , 1995, QJM : monthly journal of the Association of Physicians.

[43]  R. Silver,et al.  Induction of high levels of anticardiolipin antibodies in mice by immunization with beta 2-glycoprotein I does not cause fetal death. , 1995, American journal of obstetrics and gynecology.

[44]  H. Cohen,et al.  Immunology: Antiphospholipid antibodies and β2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach , 1995 .

[45]  G. Hughes,et al.  The management of thrombosis in the antiphospholipid-antibody syndrome. , 1995, The New England journal of medicine.

[46]  L. Carreras,et al.  Anti β2 glycoprotein I antibodies: detection and association with thrombosis , 1995 .

[47]  G. Hughes,et al.  beta 2-Glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome. , 1994, Arthritis and rheumatism.

[48]  G. Khastgir.  Pregnancy‐associated osteoporosis , 1994, British journal of obstetrics and gynaecology.

[49]  R. Silver,et al.  Recurrent Miscarriage: Autoimmune Considerations , 1994, Clinical obstetrics and gynecology.

[50]  A. Gilman‐Sachs,et al.  Down-regulation of maternal antiphospholipid antibodies during early pregnancy and pregnancy outcome. , 1994, American journal of obstetrics and gynecology.

[51]  I. Walker,et al.  The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriages , 1994, British journal of obstetrics and gynaecology.

[52]  R. Silver,et al.  Unexplained Elevations of Maternal Serum Alpha-Fetoprotein in Women With Antiphospholipid Antibodies: A Harbinger of Fetal Death , 1994, Obstetrics and gynecology.

[53]  T. Dahlman,et al.  Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. , 1993, American journal of obstetrics and gynecology.

[54]  P. Fishman,et al.  Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3. , 1993, The Journal of clinical investigation.

[55]  M. Lockshin.  Which patients with antiphospholipid antibody should be treated and how? , 1993, Rheumatic diseases clinics of North America.

[56]  R. Silver,et al.  Outcome of Treated Pregnancies in Women With Antiphospholipid Syndrome: An Update of the Utah Experience , 1992, Obstetrics and gynecology.

[57]  D. Balaban,et al.  Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. , 1992, American journal of obstetrics and gynecology.

[58]  R. Silver,et al.  Antiphospholipid antibodies and fetal loss. , 1992, The New England journal of medicine.

[59]  J. Spinnato,et al.  Should anticardiolipin tests be performed in otherwise healthy pregnant women? , 1991, American journal of obstetrics and gynecology.

[60]  R. Derksen,et al.  Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies. , 1991, European journal of obstetrics, gynecology, and reproductive biology.

[61]  K. W. Hancock,et al.  Baillière's clinical obstetrics and gynaecology , 1991 .

[62]  H. Brown,et al.  Anticardiolipin antibodies in unselected pregnant women. Relationship to fetal outcome. , 1991, Journal of perinatology : official journal of the California Perinatal Association.

[63]  S. Krilis,et al.  New aspects of anticardiolipin antibodies. , 1990, Clinical and experimental rheumatology.

[64]  T. Koike,et al.  Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease , 1990, The Lancet.

[65]  T. Barbui,et al.  Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor , 1990, The Lancet.

[66]  Branch Dw.  Antiphospholipid antibodies and pregnancy: maternal implications. , 1990 .

[67]  K. Kalunian,et al.  Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies , 1990, Obstetrics and gynecology.

[68]  J. Hobbins,et al.  The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. , 1989, American journal of obstetrics and gynecology.

[69]  D. Fulcher,et al.  PLASMA EXCHANGE AND THE ANTICARDIOLIPIN SYNDROME IN PREGNANCY , 1989, The Lancet.

[70]  M. Druzin,et al.  Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. , 1989, American journal of obstetrics and gynecology.

[71]  G. Hughes,et al.  Anticardiolipin antibodies: isotype distribution and phospholipid specificity. , 1987, Annals of the rheumatic diseases.

[72]  K. Welch,et al.  Cerebrovascular ischemia associated with lupus anticoagulant. , 1987, Stroke.

[73]  L. Jovanovič,et al.  Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. , 1985, The New England journal of medicine.

[74]  D. Gastineau,et al.  Lupus anticoagulant: An analysis of the clinical and laboratory features of 219 cases , 1985, American journal of hematology.

[75]  K. Lechner,et al.  Lupus Anticoagulants and Thrombosis , 1985 .

[76]  James L. Schardein,et al.  Chemically Induced Birth Defects , 1985 .

[77]  A. Horsman,et al.  Prolonged heparin therapy in pregnancy causes bone demineralization , 1983, British journal of obstetrics and gynaecology.

[78]  U. Vasan,et al.  Is warfarin sodium contraindicated in the lactating mother? , 1983, The Journal of pediatrics.

[79]  J. Vermylen,et al.  Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. , 1982, American Journal of Obstetrics and Gynecology.

[80]  C. Abramowsky,et al.  Decidual Vasculopathy of the Placenta in Lupus Erythematosus , 1980 .

[81]  R. Stevenson,et al.  Hazards of oral anticoagulants during pregnancy. , 1980, JAMA.

[82]  R. Pauli,et al.  Maternal and fetal sequelae of anticoagulation during pregnancy. , 1980, The American journal of medicine.

[83]  A. Breckenridge,et al.  May mothers given warfarin breast-feed their infants? , 1977, British medical journal.

[84]  A. Bourne,et al.  Recent Advances in Obstetrics and Gynæcology , 1932, The Indian Medical Gazette.